Taysha Gene Therapies’ SWOT evaluation: promising gene remedy inventory faces key catalysts By Investing.com
Taysha Gene Therapies (NASDAQ:TSHA) is a clinical-stage biotechnology firm centered on creating…
AstraZeneca raises full-year outlook as demand for therapies robust By Reuters
(Reuters) -Anglo-Swedish drugmaker AstraZeneca (NASDAQ:) on Thursday raised its gross sales and…
